Ricaborda, Louzel H.
HRN: 07-88-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2025
CEFUROXIME 500MG (TAB)
06/29/2025
07/06/2025
ORAL
500mg
BID
S/P TAHBSO
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes